Skip Navigation



Human Molecular Genetics Advance Access published online on July 27, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi293
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
14/17/2587    most recent
ddi293v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Battersby, B. J.
Right arrow Articles by Shoubridge, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Battersby, B. J.
Right arrow Articles by Shoubridge, E. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved
Received June 21, 2005
Revised July 20, 2005
Accepted July 20, 2005

Article

Mitochondrial DNA segregation in hematopoietic lineages does not depend on MHC presentation of mitochondrially-encoded peptides

Brendan J. Battersby 1, Margaret E. Redpath 1, and Eric A. Shoubridge 2*

1 Department of Human Genetics, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
2 Department of Human Genetics, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec H3A 2B4, Canada

* To whom correspondence should be addressed.
Eric A. Shoubridge, E-mail: eric{at}ericpc.mni.mcgill.ca


  Abstract

Mutations in mitochondrial DNA (mtDNA) are associated with a broad spectrum of clinical disorders. The segregation pattern of pathogenic mtDNAs is an important determinant of both the onset and severity of the disease phenotype, but the mechanisms controlling mtDNA segregation remain poorly understood. To investigate this, we previously generated heteroplasmic mice containing two different mtDNA haplotypes, and showed that BALB/c mtDNA was invariably selected over NZB mtDNA in blood and spleen. Here we have characterized this process in hematopoietic tissues, and tested whether it involves the presentation of mtDNA-encoded peptides by MHC-Ib molecules. Selection against NZB mtDNA was widespread across different hematopoietic cell lineages and proportional to heteroplasmy levels. Backcrossing heteroplasmic mice with CAST/Ei, a strain in which the MHC-Ib molecule H2-M3 is silent, completely abolished selection against NZB mtDNA in the spleen. To test whether this effect depended on an intact immune system, we generated heteroplasmic mice missing functional copies of Tap1, {beta}2m, or Rag1 to impair presentation or recognition of mtDNA-encoded peptides. The kinetics of selection against NZB mtDNA were unaltered in these mice compared to their wild-type littermates. We conclude that mtDNA selection in hematopoietic tissues is not based on an immune mechanism, but likely involves metabolic signaling.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Med. Genet.Home page
A. Pyle, R. W Taylor, S. E Durham, M. Deschauer, A. M Schaefer, D. C Samuels, and P. F Chinnery
Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation
J. Med. Genet., January 1, 2007; 44(1): 69 - 74.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.